leukemic cell lines kg1a Search Results


leukemic cell lines kg1a  (ATCC)
96
ATCC leukemic cell lines kg1a
GSEA enrichment plots based on miR-143 or miR-145 expression for the BIOCARTA_GLEEVEC ( A ), BIOCARTA_MAPK ( B ), and BIOCARTA_MTOR ( C ) pathways in MDS patient CD34 + bone marrow cells. D Imatinib dose-response curves for LEN-resistant and WT MDS-L cells following treatment for 48 h, as measured by AlamarBlue assay. E Proportion of apoptotic cells as measured by Annexin V staining for LEN-resistant and WT MDS-L cells following 144 h treatment with imatinib, LEN or vehicle (DMSO). F Colony output of LEN-resistant and WT MDS-L cells in the presence of imatinib (10 μM), LEN (1 μM) or vehicle (DMSO). Effect of inhibitors of pathways downstream of IGF-1R including everolimus (mTOR inhibitor, 0.1 μM), temsirolimus (mTOR inhibitor, 0.5 μM) and trametinib (MEK1/2 inhibitor, 0.03 μM) or LEN (1 μM) or vehicle (DMSO), on del(5q) cell lines: <t>KG1a</t> cells ( G ) and MDS-L ( H ). I Trametinib dose-response curves for LEN-resistant and WT MDS-L cells following treatment for 48 h, as measured by AlamarBlue assay. J Proportion of apoptotic cells as measured by Annexin V staining for LEN-resistant and WT MDS-L cells following 144 h treatment with trametinib (0.03 μM), LEN (1 μM) or vehicle (DMSO).
Leukemic Cell Lines Kg1a, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/leukemic cell lines kg1a/product/ATCC
Average 96 stars, based on 1 article reviews
leukemic cell lines kg1a - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
leukemic cell lines kg1a  (DSMZ)
96
DSMZ leukemic cell lines kg1a
Cytotoxic effect of Andosan on leukemia cell lines. Mean: mean of five experiments; SE: standard error. Comparison of the means of control with means of cells cultured with Andosan 10% showed a statistically significant difference ( p = 0.02).
Leukemic Cell Lines Kg1a, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/leukemic cell lines kg1a/product/DSMZ
Average 96 stars, based on 1 article reviews
leukemic cell lines kg1a - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
treatment human leukemic cell lines kg1a  (DSMZ)
93
DSMZ treatment human leukemic cell lines kg1a
Cytotoxic effect of Andosan on leukemia cell lines. Mean: mean of five experiments; SE: standard error. Comparison of the means of control with means of cells cultured with Andosan 10% showed a statistically significant difference ( p = 0.02).
Treatment Human Leukemic Cell Lines Kg1a, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/treatment human leukemic cell lines kg1a/product/DSMZ
Average 93 stars, based on 1 article reviews
treatment human leukemic cell lines kg1a - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


GSEA enrichment plots based on miR-143 or miR-145 expression for the BIOCARTA_GLEEVEC ( A ), BIOCARTA_MAPK ( B ), and BIOCARTA_MTOR ( C ) pathways in MDS patient CD34 + bone marrow cells. D Imatinib dose-response curves for LEN-resistant and WT MDS-L cells following treatment for 48 h, as measured by AlamarBlue assay. E Proportion of apoptotic cells as measured by Annexin V staining for LEN-resistant and WT MDS-L cells following 144 h treatment with imatinib, LEN or vehicle (DMSO). F Colony output of LEN-resistant and WT MDS-L cells in the presence of imatinib (10 μM), LEN (1 μM) or vehicle (DMSO). Effect of inhibitors of pathways downstream of IGF-1R including everolimus (mTOR inhibitor, 0.1 μM), temsirolimus (mTOR inhibitor, 0.5 μM) and trametinib (MEK1/2 inhibitor, 0.03 μM) or LEN (1 μM) or vehicle (DMSO), on del(5q) cell lines: KG1a cells ( G ) and MDS-L ( H ). I Trametinib dose-response curves for LEN-resistant and WT MDS-L cells following treatment for 48 h, as measured by AlamarBlue assay. J Proportion of apoptotic cells as measured by Annexin V staining for LEN-resistant and WT MDS-L cells following 144 h treatment with trametinib (0.03 μM), LEN (1 μM) or vehicle (DMSO).

Journal: Leukemia

Article Title: Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm

doi: 10.1038/s41375-025-02537-2

Figure Lengend Snippet: GSEA enrichment plots based on miR-143 or miR-145 expression for the BIOCARTA_GLEEVEC ( A ), BIOCARTA_MAPK ( B ), and BIOCARTA_MTOR ( C ) pathways in MDS patient CD34 + bone marrow cells. D Imatinib dose-response curves for LEN-resistant and WT MDS-L cells following treatment for 48 h, as measured by AlamarBlue assay. E Proportion of apoptotic cells as measured by Annexin V staining for LEN-resistant and WT MDS-L cells following 144 h treatment with imatinib, LEN or vehicle (DMSO). F Colony output of LEN-resistant and WT MDS-L cells in the presence of imatinib (10 μM), LEN (1 μM) or vehicle (DMSO). Effect of inhibitors of pathways downstream of IGF-1R including everolimus (mTOR inhibitor, 0.1 μM), temsirolimus (mTOR inhibitor, 0.5 μM) and trametinib (MEK1/2 inhibitor, 0.03 μM) or LEN (1 μM) or vehicle (DMSO), on del(5q) cell lines: KG1a cells ( G ) and MDS-L ( H ). I Trametinib dose-response curves for LEN-resistant and WT MDS-L cells following treatment for 48 h, as measured by AlamarBlue assay. J Proportion of apoptotic cells as measured by Annexin V staining for LEN-resistant and WT MDS-L cells following 144 h treatment with trametinib (0.03 μM), LEN (1 μM) or vehicle (DMSO).

Article Snippet: The leukemic cell lines KG1a, KG1, UT7, K562, U937, and THP1 were purchased from the American Type Culture Collection.

Techniques: Expressing, Alamar Blue Assay, Staining

Cytotoxic effect of Andosan on leukemia cell lines. Mean: mean of five experiments; SE: standard error. Comparison of the means of control with means of cells cultured with Andosan 10% showed a statistically significant difference ( p = 0.02).

Journal: BioMed Research International

Article Title: Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™

doi: 10.1155/2017/2059825

Figure Lengend Snippet: Cytotoxic effect of Andosan on leukemia cell lines. Mean: mean of five experiments; SE: standard error. Comparison of the means of control with means of cells cultured with Andosan 10% showed a statistically significant difference ( p = 0.02).

Article Snippet: The human leukemic cell lines KG1a, HL 60, and Meg 01 were obtained from Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (German Collection of Microorganisms and Cell Cultures), Braunschweig, Germany.

Techniques: Comparison, Control, Cell Culture